

The adapted tool has an excellent inter-rater on 123 (98 %) items and substantial to excellent test-retest reliability on 119 (91 %) items. Milestones attainment ages on the two versions differed significantly on 42 (34 %) test items. ResultsĪ total of 36 (28.8 %) test items, mostly from personal social domain, were adapted.

Reliability of the adapted tool was examined. Milestones attainment on the adapted version and the Denver II were compared on the 90 % passing age. Using 1597 healthy children 4 days to 70.6 months of age, the 25, 50, 75 and 90 % passing ages were determined for each test item as milestones. After translation into two local languages, all test items were piloted and fine-tuned. MethodsĬulture-specific test items in Denver II were modified. The objective of this study was to adapt and standardize the Denver II for assessing child development in Jimma Zone, South West Ethiopia. The Denver II is not a suitable screening test for use in South African infants, and further research is required.Due to lack of culturally relevant assessment tools, little is known about children’s developmental profiles in low income settings such as Ethiopia.

There is a slight to moderate agreement between the Denver II and the BSID III tests. The Denver II is not accurate in identifying developmental delay. The agreement between the results of the two tests were represented by a Kappa value of 0.111 for the BSID III assessed as “at risk” (p = 0.014), and 0.423 for the BSID III assessed as “handicapped” (p < 0.000). The Denver II had a specificity greater than 90%.for both BSID III composite cutoff values. 8% and 44.0% for a 14 BSID III composite score cutoff of <85 (“at risk”), and <70 (“handicapped”) respectively. The sensitivity of the Denver II in identifying developmental delay was. The results of infants that had both a Denver II and a BSID III were assessed. The study population consisted of both normal and high 10 risk neonates born between 1 July 2013 and 31 December 2015.

This is a retrospective descriptive study. The Bayley Scales of Infant and Toddler Development III (BSID III) is used as a gold standard test, to determine the level of agreement between the two tests. This article aims at assessing the accuracy of the Denver II in identifying developmental delay 6 in high risk newborns. The Denver Developmental Screening Test II (Denver II) is used to assess the development of high risk newborns at a tertiary hospital in Johannesburg.
